InvestorsHub Logo
Followers 2
Posts 71
Boards Moderated 0
Alias Born 04/01/2021

Re: None

Tuesday, 02/28/2023 10:02:01 PM

Tuesday, February 28, 2023 10:02:01 PM

Post# of 233763
competition exists for ALL INDICATIONS.
it doesn't matter if leronlimab does A B C and X Y Z and 1000 things pretty good or very good or great.
if in each indication something else is better, then leronlimab is NOT NEEDED.
talking about MOA or "we think it might be great for X" is also useless.
to get approval, to create shareholder value, to collect revenue, to help patients...
you need to EXECUTE ROBUST TRIALS AND GAIN APPROVALS.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News